CSF1R and glioblastoma: Ligand–receptor inference consistently prioritizes axes that organize this crosstalk: CSF1–CSF1R signaling supports TAM survival and polarization and is pharmacologically reprogrammable in proneural GBM; notably, CSF1R blockade remodels rather than depletes TAMs in vivo (42, 43).